Cited by 51HIV Research and TreatmentHIV/AIDS drug development and treatmentVirus-based gene therapy research

Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication

Open access
Tekeste, Shewit S., Wilkinson, Thomas A., Weiner, Ethan M., Xu, Xiaowen, Miller, Jennifer T., Le Grice, Stuart F. J., Clubb, Robert T., Chow, Samson A.·2015·Journal of Virology

Abstract

Human immunodeficiency virus type 1 (HIV-1) replication requires reverse transcription of its RNA genome into a double-stranded cDNA copy, which is then integrated into the host cell chromosome. The essential steps of reverse transcription and integration are catalyzed by the viral enzymes reverse transcriptase (RT) and integrase (IN), respectively. In vitro , HIV-1 RT can bind with IN, and the C-terminal domain (CTD) of IN is necessary and sufficient for this binding. To better define the RT-IN interaction, we performed nuclear magnetic resonance (NMR) spectroscopy experiments to map a binding surface on the IN CTD in the presence of RT prebound to a duplex DNA construct that mimics the primer-binding site in the HIV-1 genome. To determine the biological significance of the RT-IN interaction during viral replication, we used the NMR chemical shift mapping information as a guide to introduce single amino acid substitutions of nine different residues on the putative RT-binding surface in the IN CTD. We found that six viral clones bearing such IN substitutions (R231E, W243E, G247E, A248E, V250E, and I251E) were noninfectious. Further analyses of the replication-defective IN mutants indicated that the block in replication took place specifically during early reverse transcription. The recombinant INs purified from these mutants, though retaining enzymatic activities, had diminished ability to bind RT in a cosedimentation assay. The results indicate that the RT-IN interaction is functionally relevant during the reverse transcription step of the HIV-1 life cycle. IMPORTANCE To establish a productive infection, human immunodeficiency virus type 1 (HIV-1) needs to reverse transcribe its RNA genome to create a double-stranded DNA copy and then integrate this viral DNA genome into the chromosome of the host cell. These two essential steps are catalyzed by the HIV-1 enzymes reverse transcriptase (RT) and integrase (IN), respectively. We have shown previously that IN physically interacts with RT, but the importance of this interaction during HIV-1 replication has not been fully characterized. In this study, we have established the biological significance of the HIV-1 RT-IN interaction during the viral life cycle by demonstrating that altering the RT-binding surface on IN disrupts both reverse transcription and viral replication. These findings contribute to our understanding of the RT-IN binding mechanism, as well as indicate that the RT-IN interaction can be exploited as a new antiviral drug target.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jvi.01471-15

Cites

81 of 82 references verified1 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • NMR identified integrase CTD residues responsible for the integrase-RT interaction, and viruses with mutations at these positions have pronounced reverse transcription defects.

    “Studies using nuclear magnetic resonance identified amino acid residues within the IN CTD responsible for the interaction, and viruses carrying mutations at these IN positions displayed pronounced defects in reverse transcription138.”

    From Structure and function of retroviral integrase (2022) · cites this paper as [138]

  • Integrase may organize RNA within infectious particles, consistent with a proposed cofactor function during reverse transcription.

    “These data suggest that IN may have a role in organising RNA within infectious particles, which is not inconsistent with the proposed co-factor function during reverse transcription138.”

    From Structure and function of retroviral integrase (2022) · cites this paper as [138]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [2]2. Telesnitsky A, Goff SP. 1997. Reverse transcriptase and the generation of retroviral DNA, p 121-160. In Coffin JM, Hughes SH, Varmus HE (ed), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor Laboratory, NY.
  2. [4]4. Jacobo-Molina A, Arnold E. 1991. HIV reverse transcriptase structurefunction relationships. Biochemistry 30: 6351-6356. http://dx.doi.org/10 .1021/bi00240a001.

Cited by

Sorted by citations

Authors
Tekeste, S. S., Wilkinson, T. A., Weiner, E. M., Xu, X., Miller, J. T., Le Grice, S. F. J., Clubb, R. T., & Chow, S. A.
Affiliations
  • University of California, Los Angeles (US)
  • Frederick National Laboratory for Cancer Research (US)
  • Basic Research Laboratory, National Cancer Institute, Frederick, Maryland, USA
Venue
Journal of Virology
Published
2015-12
Volume
89
Issue
23
Pages
12058-12069
ISSN
  • 0022-538X (ISSN-L)
  • 1098-5514
OpenAlex
W2220328959
Cited by
51
References
78
Citations by year
2026: 4 · 2025: 12 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 6 · 2019: 1 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 1
FWCI
2.53
Type
journal article
Language
en
Open access
Locations
  • Journal of Virology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institutes of Health (1s10od016336-01a1)
  • National Institute of General Medical Sciences (T32GM008652, R01GM101416, NIH T32GM008652, GM101416)
  • National Institute of Allergy and Infectious Diseases (P30AI028697, R01AI052217)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
HIV-1, reverse transcriptase, integrase, reverse transcription, protein-protein interaction, primer binding site, viral replication, integrase mutants, antiviral drug targets, HIV-1 life cycle, single amino acid substitution
MeSH terms
Escherichia coli, Protein Binding, Virus Replication, Blotting, Western, HIV-1, DNA Primers, HIV Integrase, Nuclear Magnetic Resonance, Biomolecular, Amino Acid Substitution, Reverse Transcription, HIV Reverse Transcriptase, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review